source
- FDA advisory panel votes to add two peptides, BPC-157 and KPV, to 503A bulk compounding listThe FDA’s advisory committee voted 8-6, with one abstention, to recommend that two peptides be placed on the 503A Bulks List for bulk compounding. The recommendation covers BPC-157, proposed for ul…
- GSK secures FDA approval for lung-cancer drug Jideytro after $10.6 billion Nuvalent acquisitionGSK received FDA clearance for Jideytro, a therapy for patients with metastatic non‑small cell lung cancer that have ROS1 gene alterations and have already been treated with another targeted drug.…